Decitabine (DAC) is a small molecule nucleotide analog that is incorporated into DNA and traps human DNA methyltransferases. Although initially developed as a cytotoxic agent, low-dose DAC is enjoying a revival as a specific inhibitor of hypermethylation in cancer. DAC has activity in several hematological diseases, especially myelodysplastic syndrome, chronic myelogenous leukemia and acute myeloid leukemia. Clinical and preclinical advances are presented in this review.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
decitabine development
4
development dna
4
dna methyltransferase
4
methyltransferase inhibitor
4
inhibitor hematological
4
hematological malignancies
4
malignancies decitabine
4
decitabine dac
4
dac small
4
small molecule
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!